openPR Logo
Press release

Western Blotting Market is anticipated to expand at a CAGR of 5.4% during the forecast period 2015–2021

Western Blotting Market

Western Blotting Market

According to the latest market report published by Persistence Market Research titled “Global Market Study on Western Blotting: Increasing Prevalence of HIV and Spontaneous Research in the Field of Proteomics Fuelling the Growth of Western Blotting”, the western blotting market is expected to be valued at US$ 529.1 Mn by the end of 2015. It is anticipated to expand at a CAGR of 5.4% during the forecast period (2015–2021) to account for US$ 725.0 Mn by 2021.

Western blotting technique is considered the gold standard for the diagnosis of HIV. Western blotting, due to its high specificity and reproducibility, is used as a confirmatory test for the diagnosis of HIV. According to the World Health Organization (WHO), it is estimated that in 2013, only 51% of the people with HIV knew about their syndrome status. A major reason for low diagnosis of HIV is the fear amongst the population of getting positively diagnosed with HIV and confidentiality issues related to testing results. As per the statistics released by the joint United Nations program on HIV/AIDS, in 2013, around 35.2 Mn HIV cases were recorded with two million new cases being detected in 2014, taking the combined total for both years to 37.2 Mn. Wide application of western blotting technique in various fields such as scientific research, medical diagnostics, food & beverages industry, agricultural, and other applications is fueling the growth of the western blotting market globally.

Read Report @ https://www.persistencemarketresearch.com/market-research/western-blotting-market.asp

The growth of the western blotting market is mainly driven by rising incidence of HIV, increasing usage of western blotting in the field of proteomics, and rising demand for advancements and innovation in drug development. However, factors such as inadequate funding in developing countries, high pricing of products, and non-availability of devices in developing countries are expected to hamper overall market growth.

The western blotting market is segmented on the basis of product, application, region, and end user. North America dominated the western blotting market with over 30% share and is expected to remain dominant throughout the forecast period. Revenue from western blotting markets in Asia and Latin America are expected to expand at CAGRs of 6.2% and 6.0% respectively during the forecast period.

In terms of volume growth, reagent kits segment is expected to account for maximum share over the forecast period. Electrophoresis blotting systems segment is expected to register higher CAGR as compared to other segments in terms of volume.

Request Sample Report @ https://www.persistencemarketresearch.com/samples/3044

As western blotting is a time consuming and labor intensive process, end users are opting for automated blotting systems to address these issues. The manual technique demands continuous supervision, hence manpower is mandatory while performing this method to enhance reproducibility. Automated systems perform steps such as mixing of the solution, washing of gel, and hence reduces the time required for completion of the protocol. However, the debate regarding the trustworthiness of this technique continues across the healthcare sector, as the outcomes of tests vary according to the methodology adopted to complete the process. Selection of proper substrate and antibody is a must to achieve desired results due to the specificity of the test.

Key market players covered in this report include Thermo Fisher Scientific, Inc., GE Healthcare, Hoffmann-La Roche Ltd., Danaher Corporation (Lumigen, Inc.), EMD Millipore Corporation, Bio-Rad Laboratories, Inc., PerkinElmer Inc., LI-COR, Inc., Bio-Techne Corporation (ProteinSimple Inc.), and Advansta, Inc. These players have been profiled on the basis of various attributes such as company overview, recent developments, growth strategies, sustainability, and financial overview.

Buy now @ https://www.persistencemarketresearch.com/checkout/3044

About Us

Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.

PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.

Contact Us

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Western Blotting Market is anticipated to expand at a CAGR of 5.4% during the forecast period 2015–2021 here

News-ID: 847248 • Views:

More Releases from Persistance Market Research

Evolving Trends in the Insulin Pens Market: A Comprehensive Report
Evolving Trends in the Insulin Pens Market: A Comprehensive Report
Market Overview: The Insulin Pens Market has witnessed remarkable growth and innovation over the years. Insulin pens are medical devices used by individuals with diabetes to administer insulin easily and accurately. These devices have become an integral part of diabetes management, offering numerous advantages over traditional insulin delivery methods, such as syringes and vials. In 2022, the global market for insulin pens brought in US$ 16.2 billion in revenue and is predicted
Smart Machines Market to register growth at a CAGR of 20.1% throughout 2023-2033
The market for smart machines was valued at US$ 73,456.2 Mn in 2022, and it is expected to grow to US$ 5,44,986.6 Mn by the end of 2033. In 2023, the market for smart machines is expected to be worth US$ 87,045.6 Mn. From 2023 to 2033, the market for Smart Machines is expected to grow at a CAGR of 20.1%. The market for artificially intelligent machines and systems that can
Unified Cloud Communication and Collaboration Market will register a 11.1% CAGR by 2032
Unified Cloud Communication and Collaboration Market will register a 11.1% CAGR …
The global cloud collaboration market was valued at US$ 48 billion in 2022, and it is expected to grow at an 11.1% CAGR, likely reaching US$ 137.3 billion by the end of the forecast period, which runs from 2022 to 2032. The expansion of organizations' cross-border projects, increased productivity, and the rise of the bring your own device (BYOD) trend are some of the major factors expected to drive the
Optical Transceivers Market is Set to Grow At A CAGR Of 14.6 % By 2032
Optical Transceivers Market is Set to Grow At A CAGR Of 14.6 % By 2032
Persistence Market Research's new report "Optical Transceivers Market" examines the competitive landscape and the market's growth prospects in the coming years. The report of the Optical Transceivers market for the analysis period of 2023 - 2033 includes an in-depth study of some new and prominent industry trends, engagement analysis, and detailed regional analysis. Need More Insights on Competitor Analysis of the Smart Home Cloud Platform Market, Request for Sample https://www.persistencemarketresearch.com/samples/4798 Through

All 5 Releases


More Releases for HIV

HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus. Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral